Fenoterol

Fenoterol

Error creating thumbnail: File missing
Clinical data
Routes of administration	Inhaled
ATC code	R03AC04 (WHO) G02CA03 (WHO)
Identifiers
IUPAC name (RS)-1-(3,5-Dihydroxyphenyl)- 2-[(RS)-2-(4-hydroxyphenyl)- 1-methylethylamino]ethanol
CAS Number	13392-18-2
PubChem CID	3343
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C17H21NO4
Molar mass	303.35 g/mol

WikiDoc Resources for Fenoterol
Articles
Most recent articles on Fenoterol Most cited articles on Fenoterol Review articles on Fenoterol Articles on Fenoterol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Fenoterol Images of Fenoterol Photos of Fenoterol Podcasts & MP3s on Fenoterol Videos on Fenoterol
Evidence Based Medicine
Cochrane Collaboration on Fenoterol Bandolier on Fenoterol TRIP on Fenoterol
Clinical Trials
Ongoing Trials on Fenoterol at Clinical Trials.gov Trial results on Fenoterol Clinical Trials on Fenoterol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Fenoterol NICE Guidance on Fenoterol NHS PRODIGY Guidance FDA on Fenoterol CDC on Fenoterol
Books
Books on Fenoterol
News
Fenoterol in the news Be alerted to news on Fenoterol News trends on Fenoterol
Commentary
Blogs on Fenoterol
Definitions
Definitions of Fenoterol
Patient Resources / Community
Patient resources on Fenoterol Discussion groups on Fenoterol Patient Handouts on Fenoterol Directions to Hospitals Treating Fenoterol Risk calculators and risk factors for Fenoterol
Healthcare Provider Resources
Symptoms of Fenoterol Causes & Risk Factors for Fenoterol Diagnostic studies for Fenoterol Treatment of Fenoterol
Continuing Medical Education (CME)
CME Programs on Fenoterol
International
Fenoterol en Espanol Fenoterol en Francais
Business
Fenoterol in the Marketplace Patents on Fenoterol
Experimental / Informatics
List of terms related to Fenoterol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Fenoterol is an asthma medication designed to open up the airways to the lungs. It is classed as a beta agonist.

It was a long-acting beta-agonist widely used in New Zealand in the early 1990s but withdrawn because of its association with an excess number of deaths.

References

• Beasley R, Pearce N, Crane J, Burgess C. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):325-7.
• Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20, 1992;326(8):501-6.